$IFF

DeVeau Michael sold $755K of IFF

DeVeau Michael (EVP, CFO) sold 8,825 shares of INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) at $85.55 ($0.75M total) on 2026-08-06.

Original reporting
SEC EDGAR · DeVeau Michael
Published Aug 7, 2026, 9:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IFF
Neutral
high confidence
Mentioned
$IFF
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IFFNeutralLow
01

Why it matters

An EVP/CFO open-market sale of roughly $755k is disclosed, but the filing provides no new company performance or policy information.

02

Market read

Traders may note insider selling as a mild sentiment datapoint, but there is no fundamental catalyst in the text.

03

What to watch

No 10b5-1 plan is indicated, but the filing alone does not reveal intent, whether other tranches exist, or whether future sales are scheduled.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-07 after-hours; sale executed 2026-08-06

Background

The article is a primary-source SEC Form 4 insider transaction for International Flavors & Fragrances (IFF).

Company-level read

Ticker impact

$IFFNeutralHigh confidence
Context

IFF discloses CFO Michael DeVeau sold 8,825 shares on 2026-08-06 at $85.5490, totaling about $754,970.

Expected impact

Likely limited near-term impact; any effect would be small and short-lived unless followed by additional insider selling or new company-specific news.

Evidence & confidence

The filing is a disclosed transaction size and price, but it does not include new guidance, contracts, litigation, or operational changes that would reprice IFF fundamentals.

Market effects

Minimal; insider sales at a single large-cap fragrance/ingredients company typically do not change sector expectations.

None indicated.

None indicated.

Counterpoint

The sale may be driven by diversification, taxes, or pre-existing personal liquidity needs rather than a bearish view on IFF.

Key entities

  • INTERNATIONAL FLAVORS & FRAGRANCES INC

    Subject of the Form 4 insider transaction disclosure.

  • DeVeau Michael

    EVP, CFO who sold 8,825 shares on 2026-08-06.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IFFMed

India Opens Second Antitrust Investigation into Global Fragrance Giants

India's Competition Commission (CCI) is investigating Givaudan, dsm-firmenich, and International Flavors & Fragrances (IFF) for alleged price collusion in the fragrance industry, according to regulatory documents. The probe, separate from an ongoing anti-poaching case, was delayed after concerns over sensitive information. The companies face similar scrutiny in other markets and are cooperating. India's fragrance sector is expected to grow significantly.

$DARMedAI 8/10

A Look Back at Ingredients, Flavors & Fragrances Stocks’ Q2 Earnings: Darling Ingredients (NYSE:DAR) Vs The Rest Of The Pack

Ingredients, flavors, and fragrances stocks reported mixed Q2 earnings, with revenues missing estimates by 2.4%. Darling Ingredients (DAR) reported $1.72B revenue, up 16.4% YoY, beating estimates. Archer-Daniels-Midland (ADM) reported $22.68B revenue, up 7.2% YoY, outperforming estimates. International Flavors & Fragrances (IFF) reported $1.95B revenue, down 29.3% YoY, missing estimates. Ingredion (INGR) reported $1.85B revenue, flat YoY, topping estimates. Bunge Global (BG) reported $24.04B rev

$IFFMedAI 8/10

IFF (IFF) Q2 2026 Earnings Call Transcript

International Flavors & Fragrances (IFF) reported Q2 2026 revenue from continuing operations of $1.95 billion, up 6% currency-neutral, and adjusted EPS ex amortization of $0.82. Adjusted operating EBITDA was $408 million. The company plans a $4.3 billion Food Ingredients divestiture, $1B+ debt reduction, and a $2.5 billion share buyback. 2026 guidance: revenue $7.4B-$7.6B, EBITDA $1.53B-$1.60B.

$IFFMedAI 8/10

Read Analyst Questions From International Flavors & Fragrances’s Q2 Earnings Call

International Flavors & Fragrances (IFF) reported Q2 results driven by volume growth in Scent, Taste, and Health & Biosciences, with productivity improvements and margin discipline. Q2 revenue fell to $1.95B vs $2.61B estimates, and adjusted EPS was $0.82 vs $1.12. Full-year revenue guidance was cut to $7.5B midpoint from $10.65B. CEO said Food Ingredients divestiture is likely the last major portfolio change.

$IFFMedAI 8/10

International Flavors & Fragrances Q2 Earnings Call Highlights

International Flavors & Fragrances (IFF) reported Q2 segment results: Taste sales rose 4% to $688M, Health & Biosciences sales rose 5% to $601M, and Scent sales rose 8% to $665M. EBITDA increased across segments. IFF agreed to sell Food Ingredients to CVC for about $4.3B, and set 2026 guidance for $7.4B-$7.6B sales and $1.53B-$1.6B EBITDA.